Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin
Published: Cephalalgia, 2018.
Click here for the full article.